Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,700
Closed -$1.22M 1603
2024
Q3
$1.22M Buy
+10,700
New +$1.17M 0.02% 730
2024
Q2
Sell
-30,000
Closed -$3.41M 2016
2024
Q1
$3.41M Buy
30,000
+28,500
+1,900% +$3.27M 0.08% 178
2023
Q4
$165K Sell
1,500
-9,100
-86% -$909K ﹤0.01% 1476
2023
Q3
$1.03M Buy
10,600
+5,600
+112% +$588K 0.02% 628
2023
Q2
$545K Buy
+5,000
New +$533K 0.01% 792
2023
Q1
Sell
-10,000
Closed -$1.1M 1478
2022
Q4
$1.1M Hold
10,000
0.03% 537
2022
Q3
$968K Buy
+10,000
New +$1.07M 0.02% 633
2020
Q1
Sell
-13,600
Closed -$1.18M 579
2019
Q4
$1.18M Buy
13,600
+10,000
+278% +$838K 0.06% 265
2019
Q3
$301K Sell
3,600
-72,400
-95% -$6.15M 0.02% 440
2019
Q2
$6.39M Buy
+76,000
New +$5.98M 0.38% 51

Other funds holding ABT

Centiva Capital's ABT Position: Q1 2026 in Review

Centiva Capital sold out of Abbott (ABT) in Q1 2026, closing a stake of 13,903 shares — an estimated $1.74M sold.

Centiva Capital first reported a position in ABT in Q3 2019 and held it in 17 quarters. The position peaked at $4.42M in Q2 2024. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Centiva Capital reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 13,903 Abbott shares in Q1 2026, an estimated $1.74M.
  • Centiva Capital first reported a position in Abbott in Q3 2019 and held it in 17 quarters.
  • Centiva Capital's Abbott position peaked at $4.42M in Q2 2024.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.